Regulation of NF-κB activity in astrocytes: Effects of flavonoids at dietary-relevant concentrations

Biochemical and Biophysical Research Communications

Volumn 418, Issue 3, 2012, Pages 578-583

  Spilsbury, Alison ^a   Vauzour, David ^a,b   Spencer, Jeremy P E ^a   Rattray, Marcus ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Astrocyte; Epicatechin; Flavonoids; Inflammation; Neurodegeneration; P65; TNF

Indexed keywords

CATECHIN; CHRYSIN; EPICATECHIN; FLAVANONE; FLAVONOID; HESPERETIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KAEMPFEROL; LUCIFERASE; LUTEOLIN; NARINGENIN; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASTROCYTE; BRAIN CORTEX; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIET; DRUG BIOAVAILABILITY; ENZYME ACTIVITY; ENZYME REGULATION; GENETIC TRANSFECTION; IMMUNOCYTOCHEMISTRY; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; ASTROCYTES; CATECHIN; CELLS, CULTURED; DIET; DOWN-REGULATION; FLAVONOIDS; MICE; NF-KAPPA B; PHOSPHORYLATION; PROTEIN TRANSPORT; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84857122677     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.01.081     Document Type: Article

References (41)

1. Glass C.K., Saijo K., Winner B., Marchetto M.C., Gage F.H. Mechanisms underlying inflammation in neurodegeneration. Cell 2010, 140:918-934.
2. Volterra A., Meldolesi J. Astrocytes, from brain glue to communication elements: the revolution continues. Nat. Rev. Neurosci. 2005, 6:626-640.
3. Rossi D., Volterra A. Astrocytic dysfunction: insights on the role in neurodegeneration. Brain Res. Bull. 2009, 80:224-232.
4. Mattson M.P., Camandola S. NF-kappaB in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest. 2001, 107:247-254.
5. Yamamoto Y., Gaynor R.B. Therapeutic potential of inhibition of the NF-î°B pathway in the treatment of inflammation and cancer. J. Clin. Invest. 2001, 107:135-142.
6. Gabriel C., Justicia C., Camins A., Planas A.M. Activation of nuclear factor-[kappa]B in the rat brain after transient focal ischemia. Mol. Brain Res. 1999, 65:61-69.
7. Xie Q.W., Kashiwabara Y., Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 1994, 269:4705-4708.
8. Liu X., Buffington J.A., Tjalkens R.B. NF-[kappa]B-dependent production of nitric oxide by astrocytes mediates apoptosis in differentiated PC12 neurons following exposure to manganese and cytokines. Mol. Brain. Res. 2005, 141:39-47.
9. Dvoriantchikova G., Barakat D., Brambilla R., Agudelo C., Hernandez E., Bethea J.R., Shestopalov V.I., Ivanov D. Inactivation of astroglial NF-kappa B promotes survival of retinal neurons following ischemic injury. Eur. J. Neurosci. 2009, 30:175-185.
10. Brambilla R., Bracchi-Ricard V., Hu W.-H., Frydel B., Bramwell A., Karmally S., Green E.J., Bethea J.R. Inhibition of astroglial nuclear factor κB reduces inflammation and improves functional recovery after spinal cord injury. J. Exp. Med. 2005, 202:145-156.
11. Zhang X., Luhrs K.J., Ryff K.A., Malik W.T., Driscoll M.J., Culver B. Suppression of nuclear factor kappa B ameliorates astrogliosis but not amyloid burden in APPswe/PS1dE9 mice. Neuroscience 2009, 161:53-58.
12. Barberger-Gateau P., Raffaitin C., Letenneur L., Berr C., Tzourio C., Dartigues J.F., Alperovitch A. Dietary patterns and risk of dementia: the Three-City cohort study. Neurology 2007, 69:1921-1930.
13. Joseph J.A., Shukitt-Hale B., Denisova N.A., Bielinski D., Martin A., McEwen J.J., Bickford P.C. Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J. Neurosci. 1999, 19:8114-8121.
14. Abd El Mohsen M.M., Kuhnle G., Rechner A.R., Schroeter H., Rose S., Jenner P., Rice-Evans C.A. Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free Rad. Biol. Med. 2002, 33:1693-1702.
15. Youdim K.A., Dobbie M.S., Kuhnle G., Proteggente A.R., Abbott N.J., Rice-Evans C. Interaction between flavonoids and the blood-brain barrier: in vitro studies. J. Neurochem. 2003, 85:180.
16. Youdim K.A., Qaiser M.Z., Begley D.J., Rice-Evans C.A., Abbott N.J. Flavonoid permeability across an in situ model of the blood-brain barrier. Free Rad. Biol. Med. 2004, 36:592-604.
17. Williams R.J., Spencer J.P.E., Rice-Evans C. Flavonoids: antioxidants or signalling molecules?. Free Rad. Biol. Med. 2004, 36:838-849.
18. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J. Neurochem. 2006, 97:1634.
19. Vauzour D., Vafeiadou K., Rice-Evans C., Williams R.J., Spencer J.P. Activation of pro-survival Akt and ERK1/2 signalling pathways underlie the anti-apoptotic effects of flavanones in cortical neurons. J. Neurochem. 2007, 103:1355-1367.
20. Schroeter H., Bahia P., Spencer J.P., Sheppard O., Rattray M., Cadenas E., Rice-Evans C., Williams R.J. (-)Epicatechin stimulates ERK-dependent cyclic AMP response element activity and up-regulates GluR2 in cortical neurons. J. Neurochem. 2007, 101:1596-1606.
21. Rainey-Smith S., Schroetke L.W., Bahia P., Fahmi A., Skilton R., Spencer J.P., Rice-Evans C., Rattray M., Williams R.J. Neuroprotective effects of hesperetin in mouse primary neurones are independent of CREB activation. Neurosci. Lett. 2008, 438:29-33.
22. Bahia P.K., Rattray M., Williams R.J. Dietary flavonoid (-)epicatechin stimulates phosphatidylinositol 3-kinase-dependent anti-oxidant response element activity and up-regulates glutathione in cortical astrocytes. J. Neurochem. 2008, 106:2194-2204.
23. Vafeiadou K., Vauzour D., Lee H.Y., Rodriguez-Mateos A., Williams R.J., Spencer J.P.E. The citrus flavanone naringenin inhibits inflammatory signalling in glial cells and protects against neuroinflammatory injury. Arch. Biochem. Biophys. 2009, 484:100-109.
24. Spencer J.P.E., Vafeiadou K., Williams R.J., Vauzour D. Neuroinflammation: Modulation by flavonoids and mechanisms of action. Mol. Asp. Med. 2012, 33:83-97.
25. Tortarolo M., Crossthwaite A.J., Conforti L., Spencer J.P., Williams R.J., Bendotti C., Rattray M. Expression of SOD1 G93A or wild-type SOD1 in primary cultures of astrocytes down-regulates the glutamate transporter GLT-1: lack of involvement of oxidative stress. J. Neurochem. 2004, 88:481-493.
26. G.M. Gerondakis S., Nakamura Y., Pohl T. and Grumont R., Genetic approaches in mice to understand Rel/NF-κB and IκB function: transgenics and knockouts, Oncogene 18 (1999) 6888-6895.
27. 2+ reperfusion injury of cultured astrocytes: roles of reactive oxygen species and NF-κB activation. Eur. J. Neurosci. 1999, 11:4204-4212.
28. Clemens J.A., Stephenson D.T., Smalstig E.B., Dixon E.P., Little S.P. Global ischemia activates nuclear Factor-κB in forebrain neurons of rats. Stroke 1997, 28:1073-1081.
29. Schneider A., Martin-Villalba A., Weih F., Vogel J., Wirth T., Schwaninger M. NF-[kappa]B is activated and promotes cell death in focal cerebral ischemia. Nat. Med. 1999, 5:554-559.
30. Nair M.P., Mahajan S., Reynolds J.L., Aalinkeel R., Nair H., Schwartz S.A., Kandaswami C. The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-system. Clin. Vaccine Immunol. 2006, 13:319-328.
31. Chen Y.-C., Yang L.-L., Lee T.J.F. Oroxylin A inhibition of lipopolysaccharide-induced iNOS and COX-2 gene expression via suppression of nuclear factor-[kappa]B activation. Biochem. Pharmacol. 2000, 59:1445-1457.
32. Liang Y.C., Huang Y.T., Tsai S.H., Lin-Shiau S.Y., Chen C.F., Lin J.K. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis 1999, 20:1945-1952.
33. Lin Y.-L., Lin J.-K. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear Factor-kappaB. Mol. Pharm. 1997, 52:465-472.
34. Jeong W.-S., Kim I.-W., Hu R., Kong A.-N.T. Modulatory properties of various natural chemopreventive agents on the activation of NF-κB signaling pathway. Pharmaceutical Res. 2004, 21:661-670.
35. Kim S.-H., Shin K.-J., Kim D., Kim Y.-H., Han M.S., Lee T.G., Kim E., Ryu S.H., Suh P.-G. Luteolin inhibits the nuclear factor-[kappa]B transcriptional activity in Rat-1 fibroblasts. Biochem. Pharmacol. 2003, 66:955-963.
36. Kim J.S., Jobin C. The flavonoid luteolin prevents lipopolysaccharide-induced NF-B signalling and gene expression by blocking I B kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells. Immunology 2005, 115:375-387.
37. Kim H., Kim Y.S., Kim S.Y., Suk K. The plant flavonoid wogonin suppresses death of activated C6 rat glial cells by inhibiting nitric oxide production. Neurosci. Lett. 2001, 309:67-71.
38. Lu H., Shi J.-X., Zhang D.-M., Wang H.-D., Hang C.-H., Chen H.-L., Yin H.-X. Inhibition of hemolysate-induced iNOS and COX-2 expression by genistein through suppression of NF-κB activation in primary astrocytes. J. Neurol. Sci. 2009, 278:91-95.
39. Schreck R., Albermann K., Baeuerle P.A. Nuclear factor κB: an oxidative stress-responsive transcription factor of Eukaryotic Cells (A Review). Free Rad. Res. 1992, 17:221-237.
40. Xu Z., Chen S., Li X., Luo G., Li L., Le W. Neuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis. Neurochem. Res. 2006, 31:1263-1269.
41. Lee J.W., Lee Y.K., Ban J.O., Ha T.Y., Yun Y.P., Han S.B., Oh K.W., Hong J.T. Green tea (-)-epigallocatechin-3-gallate inhibits beta-amyloid-induced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-kappaB pathways in mice. J. Nutr. 2009, 139:1987-1993.